RUNX1 and acute myeloid leukemia: This study confirmed and extended the observations that genomic excision of a distal GATA2 enhancer led to EVI1 silencing, growth inhibition and differentiation of human AML cells with inv(3)(q21q26) or t(3;3)(q21;q26) [107].